Telomerase-associated apoptotic events by mushroom ganoderma lucidum on premalignant human urothelial cells

John W M Yuen1, Mayur Danny I Gohel, Doris Wai-Ting Au

  • 1Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Kowloon, Hong Kong SAR, China.

Nutrition and Cancer
|April 30, 2008
PubMed

Insights

Ganoderma lucidum shows potential as a chemopreventive agent for bladder cancer. It inhibits human urothelial cancer cell growth by inducing apoptosis and suppressing telomerase activity.

Area of Science:

  • Oncology
  • Pharmacology
  • Cell Biology

Background:

  • Bladder cancer poses a significant health challenge.
  • Identifying effective chemopreventive agents is crucial for early intervention.
  • Ganoderma lucidum is a medicinal mushroom with potential therapeutic properties.

Purpose of the Study:

  • To investigate the chemopreventive effects of Ganoderma lucidum on human urothelial cancer cells (HUC-PC).
  • To elucidate the mechanisms underlying the anti-cancer activity of Ganoderma lucidum in vitro.

Main Methods:

  • Utilized an in vitro model of tumorigenic transformable human urothelial cells (HUC-PC).
  • Assessed cell viability, growth, apoptosis induction (Annexin-V/7-amino-actinomycin D staining), telomerase activity, and oxidative stress markers (hydrogen peroxide, 8-hydroxy-2'-deoxyguanosine).

Main Results:

  • Ganoderma lucidum significantly inhibited HUC-PC viability and growth.
  • Demonstrated induction of apoptosis and suppression of telomerase activity in HUC-PC.
  • Observed increased production of hydrogen peroxide and 8-hydroxy-2'-deoxyguanosine in apoptotic cells, indicating oxidative stress.

Conclusions:

  • Ganoderma lucidum exhibits chemopreventive potential against bladder cancer by inhibiting premalignant urothelial cell growth.
  • Apoptosis induction and telomerase inhibition are key mechanisms of its anti-cancer effect.
  • Further research is warranted to understand the role of induced oxidative stress.

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.